Background Analysis: US FDA Advisory Committee to Hear Updates About Research at CBER– FEB 16, 2016 (CTGTAC)

The US FDA has scheduled a Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) meeting for Tuesday, February 16, 2016 from 1:00 p.m. to 5:00 p.m. The meeting will be open to the public from 1:00 p.m. to 3:55 p.m. and closed to the public from 3:55 p.m. to 5:00 p.m. The Committee will hear updates of research programs in the Tumor Vaccines and Biotechnology Branch and the Cellular and Tissue Therapy Branch of the Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapy, Center for Biologics Evaluation and Research (CBER), FDA.

See the SAC Tracker report